English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe study looked back at ultrasound data from 1,500 Black women who ended up undergoing hysterectomy at 10 health centers. The study found that having a thinner endometrium measured on transvaginal ultrasound did not mean that there was no cancer risk.
Tag: Endometrial Cancer
MD Anderson Research Highlights for May 8, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
The Foundation for Women’s Cancer to Host Free Patient and Advocates Education Forum in San Diego
The Foundation for Women’s Cancer (FWC) is pleased to host a free Patient and Advocate Education Forum on Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention Center. The organization welcomes all gynecologic cancer (cervical, endometrial/uterine, ovarian, vaginal, and vulvar) patients, advocates, family members, and providers.
ESMO: PARP inhibitor plus immunotherapy lowers risk of endometrial cancer progression over chemotherapy alone
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further benefits gained from the addition of the PARP inhibitor olaparib in maintenance setting, according to researchers from The University of Texas MD Anderson Cancer Center.
July 2023 Tip Sheet From Sylvester Comprehensive Cancer Center
A first-of-its kind drug for prostate cancer, an ancient retrovirus that may drive aggressive brain cancer, disparities in endometrial cancer rates among Black women, a new trial seeking answers for higher rates of aggressive prostate and breast cancer in Black men and women, and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Endometrial Cancer Risk and Trends Among Distinct African-Descent Populations
A new EMBARGOED study found that endometrial cancer rates in Black women are related to factors beyond ancestry, including social determinants of health such as diet, psychosocial and physiological chronic stress and neighborhood/built environmental factors.
TWO CLINICAL TRIALS REVEAL ADDITION OF IMMUNOTHERAPY TO CHEMOTHERAPY REGIMEN INCREASES PROGRESSION-FREE SURVIVAL IN ENDOMETRIAL CANCER PATIENTS
The results of two clinical trials, presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, showcased adding immunotherapy to standard chemotherapy resulted in significantly longer progression-free survival (PFS) among patients with advanced or recurrent endometrial cancer (EC).
GYNECOLOGIC CANCER PATIENTS REPORT TIME-RELATED BURDENS AND FINANCIAL TOXICITIES IMPACT QUALITY OF LIFE
Time-related and financial burdens are detrimental to gynecologic cancer patient and survivor quality of life (QOL), according to two research studies presented yesterday and today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.
The Foundation for Women’s Cancer to Host Patient and Advocates Education Forum at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in Tampa on March 24
The Foundation for Women’s Cancer will host a Patients and Advocates Education Forum and Luncheon on Friday, March 24, 2023 in Tampa, FL during the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.
UC San Diego Health Experts Available during Endometriosis Awareness Month
With Bindi Irwin recently making headlines about her personal experience with endometriosis, experts at UC San Diego Health are available to discuss a variety of topics, including causes, symptoms and treatment options to manage the condition during Endometriosis Awareness Month…
MD Anderson Research Highlights for March 8, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Structural insights reveal how SPOP protein contributes to cancer
Scientists at St. Jude Children’s Research Hospital captured the 3D structure of SPOP, revealing how mutations in previously unappreciated regions fuel cancer.
ASTRO issues updated guideline on radiation therapy for endometrial cancer
A newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy and systemic therapy after surgery to treat patients with endometrial cancer. The guideline also considers the role of surgical staging and molecular profiling techniques in determining whether a patient should receive post-operative therapy. The guideline is published in the January/February 2023 issue of Practical Radiation Oncology.
New Study Shows Sugar-Sweetened Drinks Increase Risk of Cancer Mortality
In a large study led by researchers at the American Cancer Society, men and women who drank two or more servings of sugar-sweetened beverages (SSB) per day, compared to people who never drank, had a five percent increased risk of death from an obesity-related cancer, including gastrointestinal, postmenopausal breast, endometrial and kidney cancer.
Sylvester Researchers Study Vaginal Microbiome’s Role in Screening for Endometrial Cancer
The vaginal microbiome differentiates benign disease from endometrial cancer and can even provide insight about the specific endometrial cancer type and disease severity, according to a study by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of…
Screening often misses endometrial cancer in Black women
In this study using a simulated cohort, TVUS endometrial thickness screening missed over four times more cases of endometrial cancer among Black women versus White women owing to the greater prevalence of fibroids and non-endometrioid histology type that occurs among Black women.
Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer Recurrence
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer.
Firefly Fluorescence Imaging Helps Surgeons Identify Sentinel Lymph Nodes During Robotic Endometrial Cancer Surgery
Near-infrared imaging technology prevents the removal of unnecessary lymph nodes and lowers the risk of lymphedema after surgery
Study Validates Combination Therapy for Aggressive Endometrial Cancer
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.
New, Detailed Molecular Roadmap Boosts Fight Against Endometrial Cancer
Scientists have taken an unprecedented look at proteins involved in endometrial cancer, commonly known as uterine cancer. The study offers insights about which patients will need aggressive treatment and which won’t, and offers clues about why a common cancer treatment is not effective with some patients.
Utah Researchers Discover a Key Protein in Endometrial Cancer Growth
New research, published today in the journal Cancer Research, outlines findings scientists hope will advance our understanding of endometrial cancer and lead to more effective treatments.
Grant to help UniSA researchers develop personalised cancer treatment
Personalised cancer treatment is one step closer to becoming a reality for more patients, thanks to a Cancer Council Beat Cancer Project grant awarded to University of South Australia researcher Dr Stephanie Reuter Lange to explore how computer-based modelling can optimise cancer treatment and remove the need for expensive clinical trials.